Chemoinformaics analysis of PREOCOTEINE N-OXIDE
| Molecular Weight | 387.432 | nRot | 4 |
| Heavy Atom Molecular Weight | 362.232 | nRig | 20 |
| Exact Molecular Weight | 387.168 | nRing | 4 |
| Solubility: LogS | -1.395 | nHRing | 1 |
| Solubility: LogP | 0.481 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 57.6518 |
| nHD | 1 | BPOL | 34.0322 |
| QED | 0.641 |
| Synth | 3.912 |
| Natural Product Likeliness | 1.976 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.999 |
| HIA | 0.6 |
| CACO-2 | -5.672 |
| MDCK | 0.0000165 |
| BBB | 0.136 |
| PPB | 0.483127 |
| VDSS | 1.907 |
| FU | 0.277674 |
| CYP1A2-inh | 0.033 |
| CYP1A2-sub | 0.974 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.889 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.789 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.847 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.923 |
| CL | 8.576 |
| T12 | 0.892 |
| hERG | 0.017 |
| Ames | 0.068 |
| ROA | 0.367 |
| SkinSen | 0.041 |
| Carcinogencity | 0.014 |
| EI | 0.016 |
| Respiratory | 0.18 |
| NR-Aromatase | 0.051 |
| Antiviral | Yes |
| Prediction | 0.687534 |